Article Details
Retrieved on: 2024-07-12 12:54:53
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses ResMed's positive outlook, supported by growth in MedTech, specifically in the Software as a Service (SaaS) segment. Analyst Lyanne Harrison emphasizes robust performance indicators, justifying a Buy rating and increased price target.
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here